Accumulating evidence indicates that miRNAs, a class of small non-coding RNAs, are implicated in the pathogenesis of various diseases such as cancer and intervertebral disc degeneration. The aim of this study was to investigate the expression and the biological function of microRNA-34a in intervertebral disc degeneration. In this study, microRNA-34a expression was assessed in nucleus pulposus specimens and in IL-1β-stimulated nucleus pulposus cells by real-time polymerase chain reaction. microRNA-34a functions were investigated by using gain and loss of function experiments in nucleus pulposus cells and a dual luciferase reporter assay in 293T cells. microRNA-34a was dramatically up-regulated in degenerative nucleus pulposus tissues and in IL-1β-stimulated nucleus pulposus cells when compared with controls. Furthermore, growth differentiation factor 5 was identified as a target of microRNA-34a. Aberrant expression of microRNA-34a inhibited growth differentiation factor 5 expression by direct binding to its 3′-untranslated region. This inhibition was abolished by mutation of the microRNA-34a binding sites. In addition, microRNA-34a silencing reversed IL-1β-induced decrease in type II collagen and aggrecan expression in nucleus pulposus cells. This effect was substantially suppressed by growth differentiation factor 5 silencing. Our results suggested that microRNA-34a inhibition prevents IL-1β-induced extracellular matrix degradation in human nucleus pulposus by increasing growth differentiation factor 5 expression. microRNA-34a inhibition may be a novel molecular target for intervertebral disc degeneration treatment through the prevention of nucleus pulposus extracellular matrix degradation.
CassidyJDCôtéPCarrollLJKristmanV. Incidence and course of low back pain episodes in the general population. Spine2005; 30: 2817–23.
2.
MehraMHillKNichollDSchadrackJ. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med Econ2012; 15: 245–52.
3.
BoosNWeissbachSRohrbachHWeilerCSprattKFNerlichAG. Classification of age-related changes in lumbar intervertebral discs: Volvo Award in basic science. Spine2002; 27: 2631–44.
4.
SolovievaSLohinivaJLeino-ArjasPRaininkoRLuomaKAla-KokkoLRiihimäkiH. Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. Eur Spine J2006; 15: 613–9.
5.
PyeSRReidDMAdamsJESilmanAJO'NeillTW. Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration. Ann Rheum Dis2007; 66: 426–7.
6.
GuehringTOmlorGWLorenzHBertramHSteckERichterWCarstensCKroeberM. Stimulation of gene expression and loss of annular architecture caused by experimental disc degeneration – an in vivo animal study. Spine2005; 30: 2510–5.
7.
StokesIAIatridisJC. Mechanical conditions that accelerate inter-vertebral disc degeneration: overload versus immobilization. Spine2004; 29: 2724–32.
8.
CreanJKRobertsSJaffrayDCEisensteinSMDuanceVC. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine1997; 22: 2877–84.
9.
Le MaitreCLPockertAButtleDJFreemontAJHoylandJA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans2007; 35: 652–5.
10.
SivanSSWachtelERoughleyP. Structure, function, aging and turnover of aggrecan in the intervertebral disc. Biochim Biophys Acta2014; 1840: 3181–9.
11.
KlubaTNiemeyerTGaissmaierCGründerT. Human anulus fibrosis and nucleus pulposus cells of the intervertebral disc: effect of degeneration and culture system on cell phenotype. Spine2005; 30: 2743–8.
12.
KlubaTNiemeyerTGaissmaierCGründerT. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J2013; 13: 331–41.
13.
Le MaitreCLFreemontAJHoylandJA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol2004; 204: 47–54.
14.
LeeJMSongJYBaekMJungHYKangHHanIBKwonYDShinDE. Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res2011; 29: 265–9.
15.
Le MaitreCLFreemontAJHoylandJA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther2005; 7: R732–45.
16.
HoylandJALe MaitreCFreemontAJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology2008; 47: 809–14.
17.
LiYFTangXZLiangCGHuiYMJiYHXuWQiuWChengLM. Role of growth differentiation factor-5 and bone morphogenetic protein type II receptor in the development of lumbar intervertebral disc degeneration. Int J Clin Exp Pathol2015; 8: 719–26.
18.
Le MaitreCLFreemontAJHoylandJA. Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells. Arthritis Res Ther2009; 11: R137–R137.
19.
LiXLeoBMBeckGBalianGAndersonGD. Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine2004; 29: 2229–34.
20.
GruberHEHoelscherGLIngramJABetheaSHanleyENJr. Growth and differentiation factor-5 (GDF-5) in the human intervertebral annulus cells and its modulation by IL-1β and TNF-α in vitro. Exp Mol Pathol2014; 96: 225–9.
21.
BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell2004; 116: 281–97.
AbouheifMMNakasaTShibuyaHNiimotoTKongcharoensombatWOchiM. Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology2010; 49: 2054–60.
24.
LuJGetzGMiskaEAAlvarez-SaavedraELambJPeckDSweet-CorderoAEbertBLMakRHFerrandoAADowningJRJacksTHorvitzHRGolubTR. MicroRNA expression profiles classify human cancers. Nature2005; 435: 834–8.
25.
PonomarevEDVeremeykoTBartenevaNS. Visualization and quantitation of the expression of microRNAs and their target genes in neuroblastoma single cells using imaging cytometry. BMC Res Notes2011; 4: 517–517.
26.
AghabozorgASSGhaderianSM. The role of microRNAs in cardiovascular disease. Int J Mol Cell Med2013; 2: 50–7.
27.
JingWJiangW. MicroRNA-93 regulates collagen loss by targeting MMP3 in human nucleus pulposus cells. Cell Prolif2015; 48: 284–92.
YuXLiZShenJWuWKLiangJWengXQiuG. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervertebral disc degeneration. PLoS One2013; 8: e83080–e83080.
30.
LiXJRenZJTangJH. MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis2014; 5: e1327–e1327.
31.
ZanetteDLRivadaviaFMolfettaGABarbuzanoFGProto-SiqueiraRSilva-JrWAFalcãoRPZagoMA. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res2007; 40: 1435–40.
32.
PfirrmannCWMetzdorfAZanettiMHodlerJBoosN. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine2001; 26: 1873–78.
33.
WangFWuXTZhuangSYWangYTHongXZhuLBaoJP. Ex vivo observation of human nucleus pulposus chondrocytes isolated from degenerated intervertebral discs. Asian Spine J2011; 5: 73–81.
34.
LiZShenJWuWKYuXLiangJQiuGLiuJ. The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells. J Orthop Res2013; 31: 847–57.
35.
LivakKJSchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods2001; 25: 402–8.
36.
WangHQYuXDLiuZHChengXSamartzisDJiaLTWuSXHuangJChenJLuoZJ. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol2011; 225: 232–42.
37.
LiuGCaoPChenHYuanWWangJTangX. MiR-27a regulates apoptosis in nucleus pulposus cells by targeting PI3K. PLoS One2013; 8: e75251–e75251.
38.
SannaSJacksonAUNagarajaR. Common variants in the GDF5- BFZB region are associated with variation in human height. Nat Genet2008; 2: 198–203.
39.
CuiMWanYAndersonDGShenFHLeoBMLaurencinCTBalianGLiX. Mouse growth and differentiation factor-5 protein and DNA therapy potentiates intervertebral disc cell aggregation and chondrogenic gene expression. Spine J2008; 8: 287–95.
40.
LiangHMaSYFengGShenFHJoshua LiX. Therapeutic effects of adenovirus-mediated growth and differentiation factor-5 in a mice disc degeneration model induced by annulus needle puncture. Spine J2010; 10: 32–41.
41.
WalshAJBradfordDSLotzJC. In vivo growth factor treatment of degenerated intervertebral discs. Spine2004; 29: 156–163.
